Alternative method for chromium determination in pharmaceutical drugs by HR-CS GF AAS and direct analysis of solid samples

Alternative method for chromium determination in pharmaceutical drugs by HR-CS GF AAS and direct analysis of solid samples

Accepted Manuscript Alternative method for chromium determination in pharmaceutical drugs by HR-CS GF AAS and direct analysis of solid samples Eliana...

800KB Sizes 0 Downloads 55 Views

Accepted Manuscript Alternative method for chromium determination in pharmaceutical drugs by HR-CS GF AAS and direct analysis of solid samples

Eliana G. Barrera, Débora Bazanella, Paula W. Castro, Wiliam Boschetti, Maria G.R. Vale, Morgana B. Dessuy PII: DOI: Reference:

S0026-265X(16)30647-6 doi: 10.1016/j.microc.2017.02.020 MICROC 2706

To appear in:

Microchemical Journal

Received date: Revised date: Accepted date:

21 November 2016 15 February 2017 16 February 2017

Please cite this article as: Eliana G. Barrera, Débora Bazanella, Paula W. Castro, Wiliam Boschetti, Maria G.R. Vale, Morgana B. Dessuy , Alternative method for chromium determination in pharmaceutical drugs by HR-CS GF AAS and direct analysis of solid samples. The address for the corresponding author was captured as affiliation for all authors. Please check if appropriate. Microc(2017), doi: 10.1016/j.microc.2017.02.020

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT Alternative method for chromium determination in pharmaceutical drugs by HR-CS GF AAS and direct analysis of solid samples

Eliana G. Barrera, Débora Bazanella, Paula W. Castro, Wiliam Boschetti, Maria

PT

G. R. Vale, Morgana B. Dessuy

SC

RI

ABSTRACT

High-resolution continuum source graphite furnace atomic absorption

NU

spectrometry (HR-CS GF AAS) was used to develop an analytical method for chromium determination in pharmaceutical drugs through direct analysis of solid

MA

samples. The limit of detection (LOD) and quantification (LOQ) were, respectively, 2.9 μg kg-1 and 9.7 μg kg-1 and the characteristic mass was 2.0 pg.

D

Eighteen pharmaceutical drugs and three excipients were analyzed. The

PT E

encapsulated samples were opened and only its powder content was analyzed; the tablet samples were grinded before the analysis. The results obtained from

CE

the direct analysis of the solid samples were in agreement with those found after total digestion of samples using a closed-vessel microwave oven device,

AC

with a confidence level of 95%. The Cr concentration obtained for the different capsules and tablets investigated varied between 0.05 and 1.92 mg kg -1. The proposed method is fast, reliable and simple for routine pharmaceutical analysis.

Keywords: pharmaceutical drugs, direct analysis, HR-CS GF AAS, chromium.

ACCEPTED MANUSCRIPT 1. Introduction

In the pharmaceutical industries, a variety of metals and non metals are used in the manufacture of drugs, or even used as the active pharmaceutical ingredient (API) in medicine products [1]. Thus, it is common to find metallic

PT

impurities on the final products originated from different sources, as raw

RI

materials (plants, animal proteins, etc), metal catalysts or metal reagents used

SC

during synthesis, excipients (stabilizers, fillers, release agents, flavors, color), manufacturing equipment and piping, bulk packaging, the environment, cleaning

NU

solvents, etc [2]. Considering the elements generally found in medicine formulations, chromium can be associated with potential health risks as

MA

chromosomal aberration, mutations and carcinogenicity, just to mention a few [3].

D

Taking into account the increasing consumption of pharmaceutical drugs

PT E

by humans, it is important to highlight that the quality control of these medicines is vital to guarantee the final consumers safety [1,4-6]. The permissible levels of

CE

potentially toxic elements in pharmaceuticals are usually defined by the regulatory agencies. For example, the permissible limit of Chromium impurities

AC

in drugs established from Brazilian Pharmacopeia [7] via oral use is 25 µg g-1, while the United States (USP) [8] and European Pharmacopeia (EP) [9] have settled a value of 1100 µg g-1, considering maximum daily dose of 10 g of drug products. Brazilian Pharmacopeia [7] indicates two methods for elements determination: the solid particles formation and the atomic spectrometry, which are also indicated by the USP [8] and the EP [9]. In this context, the atomic spectrometry techniques play an important role in order to determine the

ACCEPTED MANUSCRIPT potentially toxic elements concentration, as the solid particles formation test provides only semi-quantitative results. Therefore, analytical methods that provide trustworthy results through a fast and simple way are essential. Atomic absorption spectrometry (AAS) technique is recommended by Brazilian Pharmacopeia for As, Cd, Cr, Cu Hg, Ir,

PT

Mn, Ni, Os, Pb, Pd, Pt, Rh, Ru and V determination in pharmaceutical drugs [7].

RI

Among AAS techniques, graphite furnace (GF AAS) shows higher sensitivity

SC

when compared to flame AAS [10,11]. Inductively coupled plasma-optical emission spectroscopy (ICP OES) [2,12], inductively coupled plasma-mass

NU

spectrometry (ICP-MS) [13,14], electrothermal vaporization inductively coupled plasma optical emission spectrometry (ETV-ICP OES) [15] and laser ablation

MA

inductively coupled plasma-mass spectrometry (LA-ICP-MS) [16] also can be used in the analysis of pharmaceutical compounds. However, most of these

D

techniques require sample pretreatments which, besides of being time

PT E

consumable, can lead to sample losses or contamination and sensitivity decrease, mainly due to the use of different reagents and sample dilutions [10-

CE

15,17].

In this context, direct analysis of solid samples (SS) by graphite furnace

AC

atomic absorption spectrometry (SS-GF AAS) is an effective tool to overcome the issues found on the sample pretreatments [18,19]. Thus, the benefits and interests of SS-GF AAS on commercial capsules and tablets analysis arise from its simple manipulation and the possibility to be employed on industrial routine protocol. More recently, with the advent of the high-resolution continuum source AAS (HR-CS AAS), the direct analysis of solid samples by graphite furnace (HR-CS SS-GF AAS) became more consolidated and feasible [20-22].

ACCEPTED MANUSCRIPT The use of the SS-GF AAS for Cr determination is described by several authors which analyzed different matrices as medicinal plants [23], crude oil [24] tannin samples [25], biomass and its ashes [26], sunscreen samples [27], soil samples [28] and high purity polyimide samples [29]. It is noteworthy that these authors do not report the use of chemical modifiers for Cr determination. On the

PT

other hand, but still considering the employment of the SS-GF AAS, there are

RI

works that describe the use of chemical modifiers, mainly to overcome matrix

SC

interferences over the Cr analytical signal. The most common chemical modifier employed for Cr determination in different matrices, as soil certified reference

NU

materials [30], fertilizer samples [31] and vegetable oil and biodiesel samples [32], is a Mg(NO3)2 solution.

MA

All these works report that the direct analysis of solid sample is an efficient analytical tool, due to the elimination of many steps involved in the

D

sample preparation reducing the time of analysis and the risk of contamination

PT E

and it, also, avoids the sample dilution, increasing the sensitivity of the method. Moreover, the combination of direct analysis of solid samples with HR-CS AAS

CE

technique provides much more information about the spectral environmental around the analytical line, which facilitates method development and the spectral interferences and its correction. Besides these

AC

detection of

advantages, this technique has not been explored yet in order to perform the analysis of commercial pharmaceutical drugs capsules and tablets. The main goal of this work has been the development of a simple, fast and reliable analytical method for chromium determination in pharmaceutical drugs commercialized as capsules and/or tablets, as well as on excipients by HR-CS GF AAS using direct analysis of solid samples.

ACCEPTED MANUSCRIPT 2. Experimental

2.1. Instrumentation

All measurements were performed in a high-resolution continuum source

PT

graphite furnace atomic absorption spectrometer (HR-CS GF AAS), contrAA

RI

700 model (Analytik Jena, Jena, Germany). This instrument is equipped with a

SC

xenon short-arc lamp with a nominal power of 300 W operating in a hot-spot mode, a high-resolution double monochromator and a linear charge coupled

NU

device (CCD) array detector with 588 pixels. The analytical line at 357.868 nm was used for the measurements and the integrated absorbance (Aint) of center

MA

pixel (CP) and the two adjacent pixels, i.e. CP ±1, was summed and used for signal evaluation. Argon with purity of 99.996% (White Martins, São Paulo,

D

Brazil) was used as purge gas. The argon flow rate was kept in 2.0 L min-1

PT E

during all stages, except in the atomization, when it was stopped. The optimized graphite furnace temperature program for Cr determination is shown in Table 1.

CE

Transversely heated graphite tubes without a dosing hole (Analytik Jena, Part No. 407-152.316) and solid sampling graphite platform (Analytik Jena, Part

AC

No. 407–152.023), both coated with pyrolytic graphite were used in all experiments. An M2P microbalance (Sartorius, Göttingen, Germany - accuracy 0.001 mg) was used for weighing the pulverized samples directly onto the SS platforms. A pre-adjusted pair of tweezers, which is part of the SSA 6 manual solid sampling accessory (Analytik Jena, Jena, Germany), was used to transfer the SS platforms to the atomizer. The aqueous standards and digested

ACCEPTED MANUSCRIPT solutions were injected manually onto the platform using a micropipette. It was carried out 5 measurements of each sample and standard solution. A microwave reaction system, Multiwave PRO, (Anton Paar, Graz, Austria) was used for the acid digestion of the samples in order to verify the

PT

accuracy of the developed method.

SC

RI

2.2. Reagent and solutions

Analytical grade reagents were used exclusively. Ultra-pure water with a

NU

specific resistivity of 18 MΩ cm−1 from a Milli-Q water purification system (Millipore, Bedford, MA, USA) was used in the preparation of standards and

MA

digested solutions. The nitric acid (Merck, Darmstadt, Germany) used for the preparation of standards and digestions was purified by sub-boiling distillation in

D

a quartz apparatus (Kürner Analysentechnik, Rosenheim, Germany). Aqueous

PT E

standard solutions were prepared by appropriate dilutions of a stock solution of

CE

1000 mg L−1 of Cr (Specsol, São Paulo, Brazil) with 0.014 mol L−1 nitric acid.

2.3. Sample preparation procedures

AC

2.3.1. Solid sample pretreatment

Eighteen pharmaceutical drugs and three excipients were obtained from local drugstores in Porto Alegre (Rio Grande do Sul, Brazil). The encapsulated samples were opened and its powder content was analyzed without any treatment. The tablet samples (PD11, PD12, PD13 and PD17) containing an external coating layer were grinded using an agate mortar and sieved through a

ACCEPTED MANUSCRIPT 180 µm mesh. Sample masses between 0.2 and 7.5 mg of the pharmaceutical drugs or excipients were weighted onto the SS platforms and introduced into the graphite furnace for measurement. As it is not possible to weight always the same sample mass, they were transmitted to the instrument's computer to calculate the normalized Aint (calculated for 0.5 mg of sample) after each

RI

PT

measurement.

SC

2.3.2. Samples digestion and recovery tests

NU

Four samples were submitted to an acid digestion procedure in order to verify the trueness of the developed method, using a microwave system

MA

equipped with PTFE-TFM closed vessels of 50 mL. Approximately, 0.15 g of each sample was transferred to the vessels with further addition of 3 mL of

D

concentrated nitric acid and 1 mL of concentrated hydrochloric acid. The

PT E

samples were submitted to the following heating program, performed in two steps (temperature in ºC / ramp in min / hold in min): (i) 130 / 30 / 5; (ii) 180 / 20

CE

/ 5. After cooling, the vessels content were transferred to 20 mL volumetric flasks and the final volume was completed with ultrapure water. Recovery tests

AC

were carried out using these four digested samples. In this case, adequate aliquots of chromium standard solution were added to the samples before they were submitted to the digestion procedure.

(insert Table 1)

ACCEPTED MANUSCRIPT 3. Results and discussion 3.1. Temperature program

As chromium is known as thermally stable element, the method optimization and

the analyses of pharmaceutical samples were carried out without a

PT

chemical modifier. The heating program was optimized using 10 µL of an

RI

aqueous standard solution of Cr 10 µg L-1, which corresponds to 100 pg of

SC

analyte, and a commercial sample of pharmaceutical drug (PD1). Initially, pyrolysis temperatures (Tpyr) between 300 ºC and 2000 ºC were evaluated

NU

maintaining the atomization temperature at 2600 ºC. Figure 1 shows that the Cr Aint values for the aqueous standard solution and for the investigated sample

MA

are stable up to 1500 ºC and for higher temperatures the Aint values decreases due to Cr losses. In other words, it indicates that standard solution and sample

D

presents similar thermal behavior. In order to guarantee the complete matrix

PT E

elimination and to preserve the graphite furnace life time, the temperature of 1200 ºC was chosen and it was used in all further experiments. Moreover at

CE

1200 °C a better precision, which can be observed as the relative standard

AC

deviation (RSD), was obtained for the samples, RSD = 4.2 %.

(insert Figure 1)

Considering that Cr is known as a non volatile element [10], atomization temperatures (Tatom) between 2300 and 2600 °C were evaluated. It is possible to observe in Figure 2 that Cr Aint values for the PD1 sample presented a slightly increase with the temperature rising. On the other hand, the A int values

ACCEPTED MANUSCRIPT for Cr standard solution remained stable up to 2500 °C, with a small decrease at 2600 °C, which may be attributed to the Cr peak shape (Figure 3a), as at 2500 °C the analytical signal was broader and more tailing than at 2600 °C, i.e. the peak area was higher at 2500 °C than at 2600 °C. However, as a more symmetrical peak was obtained, at 2600°C, this temperature was preferable

PT

since a shorter integration time can be used, which can contribute to a improved

RI

signal to noise ratio and, consequently, lower LOD and LOQ values.

SC

Considering Cr atomization from sample, a higher atomization temperature is more convenient also, since it results in a higher amount of analyte atomized

NU

(Figure 3b).

D

MA

(insert Figure 2)

CE

PT E

(insert Figure 3)

Figure 4 shows two time-resolved absorbance spectra obtained using the

AC

optimized temperatures of 1200 and 2600 °C evaluating two different samples (PD7 and PD17). No spectral interferences and symmetric peaks are observed. Therefore, the Tpyr and Tatom used in all further measurements were 1200 and 2600 °C, respectively. It is important to mention that under these conditions the graphite furnace lifetime was approximately 330 cycles.

Furthermore,

considering the absence of spectral interferences during the samples analyses

ACCEPTED MANUSCRIPT it is clear that the pharmaceutical drugs can be directly analyzed even by a line source spectrometer.

3.2. Study of influence of sample mass

PT

The direct analysis of solid samples can find some difficulties related to

RI

inhomogeneity of samples, errors due to the use of different masses, limited

SC

sample size and high RSD values [33-35]. Hence, to check the influence of the sample mass introduced onto the graphite furnace under optimized conditions,

NU

the correlation of different masses of a pharmaceutical drug (PD1) sample and their respectively Cr Aint values were evaluated. Samples masses between 0.20

MA

and 7.5 mg were weighted and an adequate correlation coefficient (0.9850) was obtained. Higher amounts of samples were not investigated due to the platform

D

capacity, which was reasonably full when sample masses above 7.5 mg were

PT E

evaluated. This result indicates that the sample mass does not influence the

CE

analytical response, i.e., the Cr Aint.

AC

3.3. Figures of merit

Calibration curves were established using a blank and calibration solutions in the concentration range of 2.5 – 40 µg L-1 (25 – 400 pg). Blank measurements were carried out according to the “zero mass response” principle [18] using the empty SS platform.

ACCEPTED MANUSCRIPT The limits of detection (LOD) and quantification (LOQ), defined as three and ten times the standard deviation of ten measurements of the blank, respectively, both divided by the slope of the calibration curve. The characteristic mass (m0) is defined as the mass of the analyte corresponding to an integrated absorbance of 0.0044 s. The relative LOD and LOQ were

PT

calculated for 7.5 mg of sample, which corresponds to the maximum sample

RI

mass that can be analyzed.

SC

The analytical figures of merit obtained for Cr are shown in Table 2. Wollein et al. [36] measured Cr in active pharmaceutical substances with GF

NU

AAS using the Cr analytical line at 357.9 nm achieving a LOQ of 0.05 µg g-1 for 400 mg of digested samples. Using the same wavelength, De Paula et al. [37]

MA

determined Cr in pharmaceutical formulations via GF AAS using a ultrasoundassisted extraction method and obtained a LOQ of 200 ng g-1, considering a

D

sample mass of 25 mg. Virgilio et al. [23], evaluating medicinal plants via HR-

PT E

CS SS-GF AAS, determined the figures of merit for Cr using aqueous standard solutions and obtained LOQ of 11 ng g-1 and characteristic mass (m0) of 4.8 pg.

CE

Zmozinski et al. [25] determined Cr in tannin samples using HR-CS SS-GF AAS and obtained a m0 of 2.2 pg and LOQ of 57 ng g-1, calculated for 0.25 mg of

AC

sample. In other words, the figures of merit obtained in this work (m0 of 2.9 pg and LOQ of 0.39 ng g-1, calculated for a sample mass of 7.5 mg) are in agreement or even better with those reported in literature. Moreover, LOD and LOQ are comfortable lower than the maximum Cr allowed by Brazilian (25 µg g1

) and US US and European (1100 µg g-1) pharmacopeia.

(insert Table 2)

ACCEPTED MANUSCRIPT

3.4. Recovery tests and analytical results

To obtain a most reliable result, pharmaceutical drugs containing an external coating (PD11, PD12, PD13 and PD17) were grinded and sieved, as

PT

preliminary studies without sieving showed high values of RSD (> 30%). After

RI

this procedure, it was possible to achieve a better sample homogeneity, leading

SC

to more satisfactory RSD values (< 13%). Due to the lack of certified reference material for pharmaceutical drugs, the trueness of the proposed method was

NU

evaluated by comparing the results of the SS analysis with those obtained by analyzing the samples after an acid digestion. In this context, four drugs were

MA

analyzed by submitting them to a closed vessel microwave assisted acid digestion with (recovery test) and without analyte addition. The Cr

D

concentrations obtained by SS analysis and in the digested samples were

PT E

compared using the Student t-test (Table 3), with 95% of confidence level, and the results were in agreement. Moreover, these results, considering the

CE

investigated sample mass used in the acid digestion procedure (150 mg) and those employed in the direct solid sample analysis (7.5 mg maximum), confirm

AC

the samples homogeneity. The recovery values varied between 92 and 105% considering the four investigated samples. The precision of the result can be evaluated as the RSD, which was below 15% in all performed measurements (Table 3). Therefore, from the presented results for digested samples, recovery tests and RSD values, it is confirmed that the proposed method is accurate. After that, the developed method was employed for the pharmaceutical drugs and excipients analysis: eighteen pharmaceutical drugs (PD) and three

ACCEPTED MANUSCRIPT excipients (E) were analyzed. The results are shown in Table 3. The Cr concentration found are between 0.038 and 1.90 µg g -1. The results are within the stipulated values from Brazilian (25 µg g-1), US and EP (1100 µg g-1) [7-9].

PT

(insert Table 3)

SC

RI

4. Conclusion

In this work it was developed an accurate, fast and reliable analytical method for

NU

the determination of Cr in pharmaceutical drugs and excipients by HR-CS GF AAS and direct analysis of solid samples. It avoided the intensive manipulation

MA

of the samples, reducing time and cost of the analysis besides the risk of sample contamination. The developed method allows the use of aqueous

D

standards solutions for calibration, confirming that this method is simple and

PT E

suitable for routine applications. All commercial analyzed samples showed Cr content much lower than values established by current Brazilian, US and

CE

European Pharmacopeias.

AC

Acknowledgements

The authors are grateful to the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for their financial support. M.G.R.V. has scholarship from CNPq (grant no. 305679/2015-5) and W.B. (grant no. 1533/2013) and E.G.B. (grant no. 23038007479201144) from CAPES.

ACCEPTED MANUSCRIPT

References [1] N. Lewen, The use of atomic spectroscopy in the pharmaceutical industry for the determination of trace elements in pharmaceuticals. J. Pharmaceut.

PT

Biomed. 55 (2011) 653-661.

RI

[2] P. Raghuram, I.V.S. Raju, J. Sriramulu, Heavy metals testing in active

SC

pharmaceutical ingredients: an alternate approach. Pharmazie 65 (2010) 15-18. [3] E.T. Snow. Metal carcinogenesis: mechanistic implications. Pharmac. Ther.

NU

53 (1992) 31-65.

[4] G.A. Zachariadis; D.C. Kapsimali, Development of a rapid multi-element

MA

method of analysis of antitussive syrups by inductively coupled plasma atomic emission spectrometry and direct sample introduction. J. Pharmaceut. Biomed.,

D

41 (2006) 1212-1219.

PT E

[5] N. Rusu; A. Meghea, Bioaccumulation of toxic metals in fish oils capsules. U.P.B. Sci. Bull.,Series B. 77 (2) (2015) 131-140.

CE

[6] L. Chirigiu; R. Popescu; M.V. Bubulica; A. Popescu, Determination of chromium, Cooper, iron, zinc, cadmium and led by graphite furnace atomic

AC

absorption spectrometry in seven phytopharmaceutical products. Rev. Chim., 63 (9) (2012) 874-876. [7] Farmacopeia Brasileira. Brasília. Agência Nacional de Vigilância Sanitária / Fundação Oswaldo Cruz. 2010. [8] United State Pharmacopoeia, 29th ed., USP Convention, Rockville, MD, USA, 2006.

ACCEPTED MANUSCRIPT [9] European Pharmacopoeia, 5th ed., Council of Europe, Strasbourg, France, 2005. [10] B. Welz, M. Sperling, Atomic Absorption Spectrometry, 3nd ed. Weinhein: Wiley-VCH, 1999. [11] B. Welz, H. B. Ross, S. Florek, U. Heitmann, High-Resolution Continuum

PT

Source AAS: The Better Way to Do Atomic Absorption Spectrometry.1.ed.

RI

Weinhein: Wiley-VCH, 2005.

SC

[12] A. Giacomino, O. Abollino, M. Malandrino, M. Karthik, V. Murugesan, Determination and assessment of the contents of essential and potentially toxic

NU

elements in Ayurvedic medicine formulations by inductively coupled plasmaoptical emission spectrometry. Microchem. J., 99 (2011) 2–6.

MA

[13] N. Lewen, S. Mathew, M. Schenkenberger, T. Raglione, A rapid ICP-MS screen for heavy metals in pharmaceutical compounds. J. Pharmaceut.

D

Biomed., 35 (2004) 739–752.

PT E

[14] K.V. Hoecke, C. Catry, F. Vanhaecke. Optimization of sample preparation and a quadrupole ICP-MS measurement protocol for the determination of

CE

elemental impurities in pharmaceutical substances in compliance with USP guidelines. J. Anal. At. Spectrom., 27 (2012) 1909-1919.

AC

[15] S. Kaczala, A.B. Costa, E.L. Posselt, J.S. Barin, E.M.M. Flores, V.L. Dressler. Element determination in pharmaceuticals using direct solid analysisElectrothermal Vaporization Inductively Coupled Plasma Optical Emission Spectrometry. J. Braz. Chem. Soc., 26 (3) (2015) 475-483. [16] V. Rudovica, A. Viksna, A. Actins. Application of LA-ICP-MS as a rapid tool for analysis of elemental impurities in active pharmaceutical ingredients. J Pharmaceut. Biomed. 91 (2014) 119–122.

ACCEPTED MANUSCRIPT [17] R.C. Bolzan, L.F. Rodrigues, J.C.P. de Mattos, V.L. Dressler, E.M.M. Flores. Chromium determination in pharmaceutical grade barium sulfate by solid sampling electrothermal atomic absorption spectrometry with Zeemaneffect background correction. Talanta 74 (2007) 119–124.

GFAAS and ETV-ICP, Springer-Verlag, Berlin, 1998.

PT

[18] U. Kurfürst, Solid Sample Analysis - Direct and Slurry Sampling using

RI

[19] M.G.R. Vale, N. Oleszczuk, W. N.L. dos Santos, Current status of direct

SC

solid sampling for electrothermal atomic absorption spectrometry — a critical review of the development between 1995 and 2005, Appl. Spectrosc. Rev. 41,

NU

(2006) 377-400.

[20] S.O. Souza, L.L. François, A. R. Borges, M.G.R. Vale, R.G.O. Araujo.

MA

Determination of copper and mercury in phosphate fertilizers employing direct solid sampling analysis and high resolution continuum source graphite furnace

D

atomic absorption spectrometry. Spectrochim. Acta B. 114 (2015) 58-64.

PT E

[21] T.V. Silva, K. Miranda, E.C. Ferreira, M.C. Santos, J.A. Gomes Neto, F.J. Barbosa. Determination of lead in plastic food packaging by graphite furnace

CE

atomic absorption spectrometry. Atom. Spectrosc. 36 (2015) 182-186. [22] M. Resano, M. Aramendía, M.A. Belarra. High-resolution continuum source

AC

graphite furnace atomic absorption spectrometry for direct analysis of solid samples and complex materials: a tutorial review, J. Anal. At .Spectrom. 29 (2014) 2229-2250. [23] A.Virgilio, J.A. Nóbrega, J.F. Rêgo, J.A.G. Neto. Evaluation of solid sampling high-resolution continuum source graphite furnace atomic absorption spectrometry for direct determination of chromium in medicinal plants. Spectrochim. Acta B. 78 (2012) 58-61.

ACCEPTED MANUSCRIPT [24] I.M. Dittert, J.S.A. Silva, R.G.O. Araujo, A.J. Curtius, B. Welz, H. BeckerRoss. Direct and simultaneous determination of Cr and Fe in crude oil using high-resolution

continuum

source

graphite

furnace

atomic

absorption

spectrometry. Spectrochim. Acta B. 64 (2009) 537-543. [25] A.V. Zmozinski, T. Pretto, A.R. Borges, M.G.R. Vale. Determination of Cd

PT

and Cr in tannin samples by high-resolution continuum source graphit furnace

RI

atomic absorption spectrometry and direct solid sample sequential analysis

SC

(HR-CS SS-GF AAS). Anal. Methods. 7 (2015) 3735-3741.

[26] A.T. Duarte, M.B. Dessuy, M.G.R. Vale. Sequential determination of Cd

NU

and Cr in biomass samples and their ashes using high-resolution continuum source graphite furnace atomic absorption spectrometry and direct solid sample

MA

analysis. Talanta,115 (2013) 55-60.

[27] A.V. Zmozinski , T. Pretto, A.R. Borges, A.T. Duarte, M.G.R. Vale.

D

Determination of Pb and Cr in sunscreen samples by high-resolution continuum

PT E

source graphite furnace atomic absorption spectrometry and direct analysis. Microchem. J., 128 (2016) 89–94.

CE

[28] W. Boschetti, M. Orlando, M. Dullius, M.B. Dessuy, M.G.R. Vale, B. Welz, J.B. de Andrade. Sequential and simultaneous determination of four

AC

elements in soil samples using high-resolution continuum source graphite furnace atomic and molecular absorption spectrometry, J. Anal. At. Spectrom., 31 (2016) 1269. [29] R.F. Santos, G. S. Carvalho, F.A. Duarte, R.C. Bolzan, E.M.M. Flores. High purity polyimide analysis by solid sampling graphite furnace atomic absorption spectrometry, Spectrochim. Acta B, 129 (2017) 42–48.

ACCEPTED MANUSCRIPT [30] P. Török and M. Žemberyová, A study of the direct determination of Cd, Cr, Cu, Pb and Zn in certified reference materials of soils by solid sampling electrothermal atomic absorption spectrometry, Spectrochim. Acta B, 66 (2011) 93–97. [31] A.R. Borges, L.L. François, E.M. Becker, M.G.R. Vale, B. Welz. Method

PT

development for the determination of chromium and thallium in fertilizer

RI

samples using graphite furnace atomic absorption spectrometry and direct solid

SC

sample analysis, Microchem. J., 119 (2015) 169–175.

[32] J.S. Almeida, G.C. Brandão, G.L. dos Santos, L.S.G. Teixeira. Fast

NU

sequential determination of manganese and chromium in vegetable oil and biodiesel samples by high-resolution continuum source graphite furnace atomic

MA

absorption spectrometry. Anal. Methods. 8 (2016) 3249-3254. [33] M.A. Belarra, M. Resano, F. Vanhaecke, L. Moens. Direct solid sampling

D

with electrothermal vaporization/atomization: what for and how?. TrAC, Trends

PT E

Anal. Chem. 21 (2002) 828-839.

[34] J.F. Rêgo, A. Virgilio, J.A. Nóbrega, J.A.G. Neto. Determination of lead in

CE

medicinal plants by high-resolution continuum source graphite furnace atomic absorption spectrometry using direct solid sampling. Talanta 100 (2012) 21–26.

AC

[35] A.V. Zmozinski. L.D. Passos, I.C.F. Damin, M.A.B. E Santo, M.G.R. Vale, M.M. Silva. Determination of cadmium and lead in fresh fish samples by direct sampling electrothermal atomic absorption spectrometry. Anal. Methods. 5 (2013) 6416-6424. [36] U. Wollein, B. Bauer, R. Habernegg, N. Schramek. Potential metal impurities in active pharmaceutical substances and finished medicinal products – A market surveillance study. Eur. J. Pharm. Sci. 77 (2015) 100–105.

ACCEPTED MANUSCRIPT [37] C.E.R. de Paula, L.F.S. Caldas, D.M. Brum, R.J. Cassella. Development of a focused ultrasound-assisted extraction method for the determination of trace concentrations of Cr and Mn in pharmaceutical formulations by ETAAS, J.

AC

CE

PT E

D

MA

NU

SC

RI

PT

Pharmaceut. Biomed. 74 (2013) 284–290.

ACCEPTED MANUSCRIPT Table 1. Graphite furnace temperature program for Cr determination in commercial pharmaceutical drugs by HR-CS SS-GF AAS. Temperature/ºC Ramp/ºC s-1

Stage

Hold time/s

90

30

20

Drying 2

120

10

20

Pyrolysis

1200

500

30

Atomization*

2600

3000

Cleaning

2650

1000

RI

PT

Drying 1

6 5

SC

*Argon flow rate was 2.0 L min-1 in all stages, except during the atomization,

AC

CE

PT E

D

MA

NU

when it was interrupted

ACCEPTED MANUSCRIPT Table 2. Figures of merit for the determination of Cr in pharmaceutical drugs using HR-CS SS-GF AAS. Tpyr: 1200 °C and Tatom: 2600 °C Cr (357.868 nm)

Linear regression equation

A = 0.0021m (pg) + 0.0044

Correlation coefficient

0.9980

LOD (pg / ng g-1)

2.9 / 0.39a

LOQ (pg / ng g-1)

9.7 / 1.3a

RI

PT

Parameters

mo

2.0 pg

SC

a

AC

CE

PT E

D

MA

NU

LOD and LOQ calculated for the maximum sample mass used: 7.5 mg.

ACCEPTED MANUSCRIPT Table 3. Cr concentration in pharmaceutical drugs (PD) and excipients (E) samples (n = 5). Solid samples RSD

Cr

RSD

(µg g-1 ± sd)

(%)

(µg g-1 ± sd)

(%)

PD1

0.307 ± 0.023

8

PD2

0.028 ± 0.004

14

PD3

0.134 ± 0.013

10

PD4

0.808 ± 0.113

14

PD5

0.042 ± 0.003

7

PD6

0.051 ± 0.005

PD7

0.088 ± 0.003

PD8

0.152 ± 0.014

10

PD9

0.083 ± 0.002

2

PD10

0.133 ± 0.015

10

0.093 ± 0.009

10

0.184 ± 0.024

13

D

CE

PD12

PT E

PD11

RI

3

NU

SC

0.132 ± 0.004

10 3

PD13

0.577 ± 0.050

9

PD14

0.038 ± 0.004

10

PD15

0.093± 0.009

10

PD16

0.170 ± 0.021

12

PD17

1.90 ± 0.20

11

PD18

0.145 ± 0.014

10

E1

0.315 ± 0.027

9

E2

0.072 ± 0.006

9

AC

PT

Cr

MA

Sample

Digested Samples

0.085 ± 0.003

4

0.186 ± 0.010

6

1.96 ± 0.15

7

ACCEPTED MANUSCRIPT 0.143 ± 0.005

4

AC

CE

PT E

D

MA

NU

SC

RI

PT

E3

ACCEPTED MANUSCRIPT FIGURE CAPTIONS Figure 1: Pyrolysis curves for Cr evaluating a (□) pharmaceutical drug (PD1) with the Aint values normalized to a sample mass of 0.5 mg and () a Cr (100 pg) aqueous standard solution. Tatom = 2600 ºC. Figure 2: Atomization curves for Cr evaluating a (□) pharmaceutical drug (PD1) with the Aint values normalized to a sample mass of 0.5 mg and () a Cr (100 pg) aqueous standard solution. Tpyr = 1200 ºC.

PT

Figure 3. Absorbance signal at (─) 2500 ºC and (--) 2600 ºC for chromium in (a) aqueous standard solution (100 pg) and (b) pharmaceutical drug (PD1).

AC

CE

PT E

D

MA

NU

SC

RI

Figure 4: Time-resolved absorbance spectra of Cr for (a) PD7 (m = 0.719 mg, Aint = 0.1167) and (b) PD17 (m =0.108 mg, Aint = 0.4247) pharmaceutical drugs samples. Tpyr = 1200 °C and Tatom = 2600 °C.

ACCEPTED MANUSCRIPT

AC

CE

PT E

D

MA

NU

SC

RI

PT

Fig. 1

ACCEPTED MANUSCRIPT

AC

CE

PT E

D

MA

NU

SC

RI

PT

Fig. 2

AC

CE

PT E

D

MA

NU

SC

RI

PT

ACCEPTED MANUSCRIPT

NU

SC

RI

PT

ACCEPTED MANUSCRIPT

AC

CE

PT E

D

MA

Fig. 3

AC

CE

PT E

D

MA

NU

SC

RI

PT

ACCEPTED MANUSCRIPT

MA

NU

SC

RI

PT

ACCEPTED MANUSCRIPT

AC

CE

PT E

D

Fig. 4

ACCEPTED MANUSCRIPT Highlights  Metals contamination in pharmaceutical drugs and excipients.  Chromium determination in pharmaceutical drugs.  Use of direct analysis of solid samples by graphite furnace atomic absorption

PT

spectrometry  A fast, reliable and simple method was developed for routine pharmaceutical

RI

analysis

AC

CE

PT E

D

MA

NU

SC

 No spectral interferences and symmetrical peaks were obtained.